Smart Transportation Market Report 2025-2030: Key Opportunities for Integration along with Solutions and Services by Smart Transportation Market Function – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Smart Transportation Market by Technology, Solution Type, Transport Mode, Business Model, and Vehicle Types 2025 –... Read more.
OS Therapies Awarded OST-HER2 Clinical Trial Data Presentation at MIB Agents FACTOR Osteosarcoma Conference
NEW YORK–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates... Read more.
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults
Miniature, twice-yearly GLP-1 (exenatide) implant under development for chronic weight management NPM-115 has demonstrated comparable preclinical weight loss to... Read more.
Spire Global Announces $40.0 Million Private Placement
VIENNA, Va.–(BUSINESS WIRE)–$SPIR—Spire Global, Inc. (NYSE: SPIR) (“Spire” or “the Company”), a global provider of space-based data, analytics... Read more.
Comvest Partners Celebrates 25 Years of Investment Management Leadership
WEST PALM BEACH, Fla.–(BUSINESS WIRE)–#25thanniversary–Comvest Partners (“Comvest”) is proud to recognize its 25th anniversary in 2025. Since... Read more.
BondBloxx and IR+M Extend Leadership in Tax-Aware Fixed Income ETFs With Launch of Two New Funds
TXXI and TAXM build on the success of TAXX, addressing growing demand for core tax-aware solutions. LARKSPUR, Calif. & BOSTON–(BUSINESS WIRE)–BondBloxx... Read more.
Acacia Research Corporation Reports Fourth Quarter and Year End 2024 Financial Results
Consolidated Revenue of $48.8 Million for the Quarter, and $122.3 Million for the Year GAAP Net Income (Loss) of $(13.4) Million for the Quarter, and $(36.1) Million... Read more.
PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis
– The Alnylam Act® program is a genetic testing initiative designed to enable improved patient diagnosis of three rare, devastating, and life-threatening genetic... Read more.
Build-A-Bear Workshop Reports Record-Breaking Fourth Quarter and Fiscal 2024 Results; Increases Quarterly Dividend
ST. LOUIS–(BUSINESS WIRE)–Build-A-Bear Workshop, Inc. (NYSE: BBW) today announced results for the fourth quarter of fiscal year 2024 ended February 1,... Read more.
ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.
Programs to be Driven Through Patented AI Technology and Advanced Proprietary B Cell Platforms Partnership advances next-generation ADCs and bispecific antibodies... Read more.